Paxlovid can only be prescribed to people within the first five days of a COVID-19 infection. Even if you're at risk for a severe infection, you may not necessarily be prescribed the treatment.

Paxlovid, Pfizer's oral treatment for COVID-19, became available to eligible patients in Alberta for the first time on Monday. The province has an initial stockpile of 3,200 sets of pills.

1:47 Doctors call for better access to COVID-19 treatment drug Paxlovid Reports of two patients who found relief from long COVID after taking Pfizer Inc’s antiviral Paxlovid, including a ...

Anyone experiencing moderate or severe COVID-19 symptoms such as extreme difficulty breathing is still advised to go to an emergency department or call 911. Treatment with Paxlovid – six pills a ...

Paxlovid is the most commonly prescribed at home treatment for COVID-19 in the U.S. It is approved to treat COVID in adults who are at risk of severe complications from the illness.

"Paxlovid is just yet another piece of the puzzle that helps us manage this illness in people who may be at more risk," said Dr. Gerald Evans of the new COVID-19 treatment.

OTTAWA - Health Canada authorized the first at-home, oral treatment for COVID-19 Monday. But what is Paxlovid, how does it work and who can get it? Here are some answers.

TORONTO - Ontario is prioritizing older, unvaccinated residents and immunocompromised individuals for a new antiviral COVID-19 treatment, as limited supplies become available across the province.

Paxlovid is an antiviral combination therapy that can reduce the risk of COVID-19 causing severe illness, hospitalization and ...

The antiviral drug Paxlovid is great at treating COVID-19 infections, but a new study casts doubt on its effectiveness at preventing symptoms associated with long COVID. Nearly 9,600 veterans given ...

Nirmatrelvir is a protease inhibitor that stops the SARS-CoV-2 virus from replicating while ritonavir boosts the activity of nirmatrelvir. It is given in a five-day course with three pills taken twice ...

As provinces and territories across the country face criticism for not making the at-home COVID-19 antiviral treatment Paxlovid more accessible, the N.W.T. government says it's made doses available in ...